These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38007007)

  • 1. circWSB1 promotes tumor progression in ccRCC via circWSB1/miR-182-5p/WSB1 axis.
    Tang G; Liu J; Gao X; Tang W; Chen J; Wu M; Lv Z; Zhang Y; Cai Y; Qi L
    Int J Biol Macromol; 2024 Jan; 256(Pt 1):128338. PubMed ID: 38007007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.
    Gui CP; Liao B; Luo CG; Chen YH; Tan L; Tang YM; Li JY; Hou Y; Song HD; Lin HS; Xu QH; Yao GS; Yao HH; Xi-Liu ; Luo JH; Cao JZ; Wei JH
    Mol Cancer; 2021 Dec; 20(1):169. PubMed ID: 34922539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression.
    Zheng Z; Chen Z; Zhong Q; Zhu D; Xie Y; Shangguan W; Xie W
    Cancer Sci; 2021 Apr; 112(4):1443-1456. PubMed ID: 33453148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive profiling of circRNAs and the tumor suppressor function of circHIPK3 in clear cell renal carcinoma.
    Li H; Heng B; Ouyang P; Xie X; Zhang T; Chen G; Chen Z; Cheang K; Lai C
    J Mol Histol; 2020 Jun; 51(3):317-327. PubMed ID: 32409849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of circular RNA PUM1 inhibits clear cell renal cell carcinoma progression through the miR-340-5p/FABP7 axis.
    Zeng F; Luo L; Song M; Li D
    J Recept Signal Transduct Res; 2022 Apr; 42(2):141-150. PubMed ID: 33472512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma.
    Wei X; Dong Y; Chen X; Ren X; Li G; Wang Y; Wang Y; Zhang T; Wang S; Qin C; Song N
    Aging (Albany NY); 2020 Nov; 12(23):24184-24207. PubMed ID: 33223511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals.
    Wang K; Sun Y; Tao W; Fei X; Chang C
    Cancer Lett; 2017 May; 394():1-12. PubMed ID: 28089832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma.
    Lv Q; Wang G; Zhang Y; Shen A; Tang J; Sun Y; Ma C; Wang P
    J Exp Clin Cancer Res; 2021 Feb; 40(1):76. PubMed ID: 33618745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ_RPL23A acts as a miR-1233 sponge to suppress the progression of clear cell renal cell carcinoma by promoting ACAT2.
    Cheng L; Cao H; Xu J; Xu M; He W; Zhang W; Dong L; Chen D
    J Bioenerg Biomembr; 2021 Aug; 53(4):415-428. PubMed ID: 34036483
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Liu Q; Lei C
    Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. circPLIN2 promotes clear cell renal cell carcinoma progression by binding IGF2BP proteins and miR-199a-3p.
    Zhao B; Huang C; Pan J; Hu H; Liu X; Zhang K; Zhou F; Shi X; Wu J; Yu B; Chen X; Zhang W
    Cell Death Dis; 2022 Dec; 13(12):1030. PubMed ID: 36494341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circDVL1 inhibits clear cell renal cell carcinoma progression through the miR-412-3p/PCDH7 axis.
    Wang Y; Zhang Y; Su X; Qiu Q; Yuan Y; Weng C; Zou S; Tian Y; Han W; Liu P; Guo X; Mao J; Fu X; Wang P; Lin W
    Int J Biol Sci; 2022; 18(4):1491-1507. PubMed ID: 35280687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
    Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
    Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p.
    Li J; Huang C; Zou Y; Ye J; Yu J; Gui Y
    Mol Cancer; 2020 Jun; 19(1):103. PubMed ID: 32503552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis.
    Zheng Z; Zeng X; Zhu Y; Leng M; Zhang Z; Wang Q; Liu X; Zeng S; Xiao Y; Hu C; Pang S; Wang T; Xu B; Peng P; Li F; Tan W
    Mol Cancer; 2024 Jan; 23(1):4. PubMed ID: 38184608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
    Deng JH; Zheng GY; Li HZ; Ji ZG
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-155-5p Promotes Cell Proliferation and Migration of Clear Cell Renal Cell Carcinoma by Targeting PEG3.
    Wu H; Wu H; Sun P; Zhu D; Ma M; Fan W
    Urol Int; 2021; 105(9-10):906-915. PubMed ID: 34192708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
    Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
    J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis.
    Liu G; Zhou J; Piao Y; Zhao X; Zuo Y; Ji Z
    Aging (Albany NY); 2020 Jun; 12(12):11530-11549. PubMed ID: 32541093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ-AKT3 inhibits clear cell renal cell carcinoma metastasis via altering miR-296-3p/E-cadherin signals.
    Xue D; Wang H; Chen Y; Shen D; Lu J; Wang M; Zebibula A; Xu L; Wu H; Li G; Xia L
    Mol Cancer; 2019 Nov; 18(1):151. PubMed ID: 31672157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.